ADARx Pharmaceuticals (ADRX) Finishes 13.8% Above IPO Price After Strong Opening

September 25, 2026

ADARx Pharmaceuticals Inc. (Nasdaq: ADRX) delivered a strong opening in its public-market debut, opening at $22.10, exactly 30.0% above its $17.00 IPO price. The company priced at the top of its marketed $15.00-$17.00 range and increased the offering to 26.25 million shares, raising $446.25 million.

The strong opening reflected significant initial demand, with ADRX reaching an intraday high of $23.21. However, the early strength did not hold. Shares gradually moved lower during the session before selling accelerated later in the afternoon, eventually taking ADRX to an intraday low of $19.05.

Neutral Sentiment Throughout the Session

Despite the deterioration in price, IPO Prophet's quantitative sentiment model opened Neutral and remained Neutral throughout the entire trading session. No Bearish Sentiment signal was generated.

That distinction is important. While ADRX gave back a meaningful portion of its opening premium, the price action did not meet IPO Prophet's threshold for a bearish signal.

ADRX ultimately closed at $19.35, down 12.44% from its $22.10 opening price, but still 13.82% above its $17.00 IPO price. The session therefore produced two very different perspectives: investors receiving IPO allocations still finished the day with a double-digit gain, while investors purchasing shares at the opening experienced a meaningful decline.

Strong Bookbuilding, More Cautious Secondary Trading

The offering was led by J.P. Morgan, Morgan Stanley, TD Cowen and UBS, giving ADARx a strong group of bookrunners for one of the larger biotechnology IPOs of 2026.

The upsized transaction and top-of-range pricing demonstrated substantial institutional demand during the bookbuilding process, while the first day of trading showed that investors became considerably more price-sensitive once the shares moved substantially above the IPO price.

IPO Prophet Takeaway

ADRX is a good example of why investors should not automatically buy the opening print of a strong IPO. The stock opened 30.0% above the IPO price, but IPO Prophet was not Bullish at the open — our quantitative sentiment model opened Neutral and remained Neutral throughout the session.

That distinction proved important as ADRX gave back much of its opening premium and finished 12.44% below the $22.10 opening price. The IPO itself still produced a solid first-day gain, but the Neutral signal indicated that IPO Prophet was not confirming the opening strength as a Bullish setup and helped illustrate the risk of chasing an extended opening price.